Danone to close US dairy-alternatives factory
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Danone's closure of the Bridgeton plant signals a strategic pivot towards higher-margin, high-growth segments like yogurt, while consolidating production to improve EBITDA margins in a maturing plant-based market. However, the panelists raised concerns about potential volume loss due to private label competition and the risk of service disruptions or capex creep in the absorption plants.
Risk: Losing pricing power and volume to private label competitors due to reduced agility in responding to market changes.
Opportunity: Improving EBITDA margins through consolidation and focusing on higher-margin, high-growth segments like yogurt.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Danone is to shut a dairy-alternatives factory in the US making products under the Silk and So Delicious Dairy Free brands.
The French group plans to close the site in Bridgeton, New Jersey on 4 August. The move will affect around 114 employees, the company told *Just Drinks*.
The facility produces Silk and So Delicious Dairy Free drinks. Danone said production will be transferred to three other plants in Mt. Crawford, Virginia, Dallas, Texas and Jacksonville, Florida.
"This change is part of a broader effort to transform our network and enables our investment in critical capabilities across our core US footprint for the long term," Danone said.
The company does not provided detailed financials on product segments in specific markets. However, when the group published its 2025 results in February, CFO Juergen Esser said Danone's plant-based business in North America had an “unsatisfactory performance” last year.
According to a report from the Good Food Institute, based on SPINS retail sales data, plant-based milk remained the largest plant-based category in the US in 2025, with sales of $2.7bn and a 13% share of total retail milk sales.
However, category sales slipped 2% year-on-year.
The report said some sub-segments performed better, with soy milk dollar sales rising 4% and coconut milk up 27%, while several adjacent plant-based categories including yogurt, creamers and ready-to-drink beverages also posted growth.
The planned closure in New Jersey contrasts with Danone’s expansion moves elsewhere in its network.
Last month, Danone said it will invest some €20m ($23.5m) to expand its skyr production in France.
In November, the company announced a “major” investment at a factory in Canada. The expansion of the site in Boucherville will increase yogurt output at the plant by 40% and its raw milk processing capacity by 20%.
In August last year, the company set out plans to expand its Minster yogurt factory in Ohio, which produces brands such as Oikos, Activia, Dannon and Danimals.
"Danone to close US dairy-alternatives factory" was originally created and published by Just Drinks, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Four leading AI models discuss this article
"The Bridgeton closure is a necessary rationalization of Danone's US supply chain to defend margins in a cooling plant-based category."
Danone’s closure of the Bridgeton facility is a clear signal of capital discipline in a struggling category. While North American plant-based sales slipped 2% year-over-year, the strategic pivot toward higher-margin, high-growth segments like yogurt—evidenced by their recent investments in Ohio and Canada—suggests management is aggressively pruning underperforming assets. Consolidating production into three existing plants likely aims to capture economies of scale and improve EBITDA margins as the plant-based market moves from speculative hype to a mature, price-sensitive phase. This isn't a retreat from the US; it's an optimization of the footprint to protect cash flow while dairy-based core products remain the primary engine for profitability.
Consolidating production into fewer sites increases supply chain fragility; a single disruption in Virginia, Texas, or Florida could now paralyze the entire Silk and So Delicious supply chain.
"The New Jersey closure underscores Danone's US plant-based struggles, signaling a strategic de-emphasis that could weigh on NA margins despite production transfers and global dairy investments."
Danone (BN.PA) closing its New Jersey Silk/So Delicious plant—affecting 114 jobs—flags ongoing weakness in US plant-based dairy alternatives, where CFO Juergen Esser called 2024 NA performance 'unsatisfactory' amid a 2% YoY sales drop to $2.7bn for the category (13% of total milk). Production shifts to Virginia, Texas, and Florida aim for network efficiency, but without financials, it smells like cost-cutting in a maturing, low-growth segment (soy +4%, coconut +27%, but overall slippage). Contrasts sharply with €20m French skyr expansion, 40% Canadian yogurt boost, and Ohio dairy upgrades—telegraphing a pivot to high-margin core dairy, potentially freeing capex but risking NA market share erosion.
This is proactive optimization, not retreat: consolidating into three plants preserves full Silk capacity while trimming redundant costs, positioning Danone to capitalize on resilient subsegments like coconut milk amid broader dairy strength.
"This is capital reallocation away from a stalling category toward higher-margin dairy, not a sign of fundamental weakness in Danone's portfolio."
Danone is consolidating plant-based production into three existing facilities—a rational cost move, not a strategic retreat. The real story: plant-based milk sales fell 2% YoY despite being a $2.7bn category, yet Danone is doubling down on dairy (yogurt expansion in Ohio, Canada, France). The closure signals Danone sees better returns in premium yogurt and skyr than commodity plant-based drinks. Losing 114 jobs in New Jersey is real pain, but the capital reallocation toward higher-margin dairy categories suggests management sees the plant-based narrative as overblown. The article frames this as weakness; it's actually disciplined portfolio pruning.
If plant-based milk is still 13% of total US milk retail despite the 2% decline, Danone may be exiting too early—ceding share to Oatly or private label just as the category stabilizes. Consolidation could also mean higher unit costs per facility if Bridgeton had unique scale advantages.
"The closure is a deliberate cost-and-capacity rationalization intended to lift long-term margins, but it heightens near-term supply and earnings risk for Silk/So Delicious in the US until volume absorption across the new sites proves up."
Danone's shutdown of the Bridgeton dairy-alternatives plant appears to be a network rationalization rather than a verdict on demand. Moving Silk/So Delicious output to three other U.S. plants could lower fixed costs and better align capacity with higher-margin core dairy offerings, improving long-run margins. Yet several gaps remain: the size of one-off costs or severance, whether the three absorption sites can scale without service disruptions, and if the near-term revenue impact is offset by efficiency gains. The broader context shows U.S. plant-based milk remains large but uneven in growth, with some sub-segments thriving while overall category softens. Execution risk and timing matter as much as the headline shift.
Against this neutral read, the strongest case is that it signals structural demand softness for US plant-based drinks and could create near-term supply risk if the absorbing plants lag. If the cost savings are overstated or delayed, the cash-flow impact could be negative rather than accretive.
"Consolidation risks ceding pricing power and market share to private label competitors in the price-sensitive plant-based category."
Claude, you’re missing the competitive threat: private label. By consolidating into fewer, potentially less specialized facilities, Danone risks losing the agility needed to combat store-brand encroachment in the plant-based aisle. While you view this as 'disciplined pruning,' it looks like a classic defensive retreat that cedes pricing power. If Danone can't defend its premium shelf space against cheaper alternatives, these 'efficiency gains' will be cannibalized by volume loss within 18 months.
"Consolidation into existing Silk plants limits agility loss, but reallocates capex to dairy at potential cost to plant-based rebound."
Gemini, your private label agility fear overstates it—the three target plants (VA, TX, FL) are established Silk sites, per announcement, minimizing specialization loss. Bigger miss across panel: no capex numbers, but €20m French skyr + Ohio upgrades signal $50m+ shift from plant-based (speculative scale). Ties Grok's subsegment strength (coconut +27%)—Danone risks missing rebound if absorption caps volume upside.
"Absorption capacity at three plants is the hidden capex and execution risk that determines whether this is optimization or false economy."
Grok's capex reallocation thesis ($50m+ shift) is speculative without actual numbers. But the real gap: nobody's quantified absorption risk. Can Virginia, Texas, Florida plants absorb Bridgeton's volume without capex themselves? If yes, margins improve. If no, Danone faces either capex creep that negates savings or service failures that hand share to Oatly. That's the execution knife-edge everyone's dancing around.
"Absorption and timing risks could wipe out any margin gains from the plant consolidation unless numbers prove scalable."
Grok, your €50m+ capex reallocation thesis is unsubstantiated without numbers on absorption and speed. If Virginia, Texas, and Florida can’t soak Bridgeton’s volume without creeping costs, the supposed margin uplift may vanish. The panel discussion should quantify ramp-up costs, service disruption risks, and SKU breadth at the three sites; otherwise this looks like cost-cutting that trades near-term profitability for longer-term reliability issues or share loss to Oatly/private label.
Danone's closure of the Bridgeton plant signals a strategic pivot towards higher-margin, high-growth segments like yogurt, while consolidating production to improve EBITDA margins in a maturing plant-based market. However, the panelists raised concerns about potential volume loss due to private label competition and the risk of service disruptions or capex creep in the absorption plants.
Improving EBITDA margins through consolidation and focusing on higher-margin, high-growth segments like yogurt.
Losing pricing power and volume to private label competitors due to reduced agility in responding to market changes.